The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Radiotherapy: do WBRT/PCI still have a role in NSCLC/SCLC?

Name: Radiotherapy: do WBRT/PCI still have a role in NSCLC/SCLC?
Uploaded: 2020-01-29T00:00:00Z
Duration: 4 min 23 s
Description: Riyaz Shah, FRCP, PhD, The Royal Marsden Hospital, London, UK, discusses why the use of whole brain radiotherapy (WBRT) for non-small cell lung cancer (NSCLC) & prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC) is being revisited. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Riyaz Shah • 29 Jan 2020

BTOG 2020

Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

Riyaz Shah, FRCP, PhD, The Royal Marsden Hospital, London, UK, discusses why the use of whole brain radiotherapy (WBRT) for non-small cell lung cancer (NSCLC) & prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC) is being revisited. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.